Mark van Duin

Mark van Duin

UNVERIFIED PROFILE

Are you Mark van Duin?   Register this Author

Register author
Mark van Duin

Mark van Duin

Publications by authors named "Mark van Duin"

Are you Mark van Duin?   Register this Author

28Publications

542Reads

-Profile Views

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2019 01 10;10(1):213. Epub 2019 Jan 10.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-08107-8
Publisher Site
http://dx.doi.org/10.1038/s41467-018-08107-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328616PMC
January 2019

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Nat Commun 2018 09 13;9(1):3707. Epub 2018 Sep 13.

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-04989-w
Publisher Site
http://dx.doi.org/10.1038/s41467-018-04989-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137048PMC
September 2018

MCL1 gene co-expression module stratifies multiple myeloma and predicts response to proteasome inhibitor-based therapy.

Genes Chromosomes Cancer 2018 08;57(8):420-429

School of Life Sciences, Beijing Key Laboratory of Gene Resource and Molecular Development, Laboratory of Neuroscience and Brain Development, Beijing Normal University, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.2DOI Listing
August 2018

Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma.

Haematologica 2017 08 20;102(8):e317-e320. Epub 2017 Apr 20.

Department of Oncology, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.162198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541886PMC
August 2017

Multiple myeloma.

Nat Rev Dis Primers 2017 Jul 20;3:17046. Epub 2017 Jul 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2017.46DOI Listing
July 2017

The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá.

Expert Rev Pharmacoecon Outcomes Res 2017 Jun 25;17(3):303-310. Epub 2016 Oct 25.

a Department of Health Services Research, CAPHRI School for Primary Care & Public Health , Maastricht University , Maastricht , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1246185DOI Listing
June 2017

The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.

J Natl Cancer Inst 2007 Mar;99(5):396-406

Department of Pathology, Leiden University Medical Center, PO Box 9600 L1-Q, 2300 RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djk067DOI Listing
March 2007

Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.

Anticancer Res 2006 Mar-Apr;26(2A):1193-200

Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
May 2006

Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22.

Int J Cancer 2003 Jul;105(5):577-82

Department of Pathology, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.11145DOI Listing
July 2003